COVID-19 sepsis and microcirculation dysfunction

A Colantuoni, R Martini, P Caprari, M Ballestri… - Frontiers in …, 2020 - frontiersin.org
The spreading of Coronavirus (SARS-CoV-2) pandemic, known as COVID-19, has caused a
great number of fatalities all around the World. Up to date (2020 May 6) in Italy we had more …

COVID-19 and cardiovascular consequences: Is the endothelial dysfunction the hardest challenge?

S Del Turco, A Vianello, R Ragusa, C Caselli… - Thrombosis research, 2020 - Elsevier
Abstract A Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) has become
a pandemic disease named Coronavirus Disease-19 (COVID-19) of epochal dimension …

The compelling arguments for the need of microvascular investigation in COVID-19 critical patients

R Martini - Clinical hemorheology and microcirculation, 2020 - content.iospress.com
The burden of pandemic COVID-19 is growing worldwide, as the continuous increases of
contagion. Only 10–15% of the entire infected population has the necessity of intensive care …

Immunoinflammatory, thrombohaemostatic, and cardiovascular mechanisms in COVID-19

S Gencer, M Lacy, D Atzler… - Thrombosis and …, 2020 - thieme-connect.com
The global coronavirus disease 2019 (COVID-19) pandemic has deranged the recent
history of humankind, afflicting more than 27 million individuals to date. While the majority of …

Endothelial dysfunction in COVID-19: a unifying mechanism and a potential therapeutic target

P Ambrosino, IL Calcaterra, M Mosella, R Formisano… - Biomedicines, 2022 - mdpi.com
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) generated a
worldwide emergency, until the declaration of the pandemic in March 2020. SARS-CoV-2 …

Pathophysiology of COVID-19: critical role of hemostasis

SA Andrade, DA de Souza, AL Torres… - Frontiers in cellular …, 2022 - frontiersin.org
The COVID-19 pandemic, caused by SARS-CoV-2, had its first cases identified in late 2019
and was considered a clinical pandemic in March 2020. In March 2022, more than 500 …

Endothelial dysfunction in COVID-19: potential mechanisms and possible therapeutic options

MC Pelle, I Zaffina, S Lucà, V Forte, V Trapanese… - Life, 2022 - mdpi.com
SARS-CoV-2, a novel coronavirus found in Wuhan (China) at the end of 2019, is the
etiological agent of the current pandemic that is a heterogeneous disease, named …

Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic …

PC Evans, GE Rainger, JC Mason… - Cardiovascular …, 2020 - academic.oup.com
The COVID-19 pandemic is an unprecedented healthcare emergency causing mortality and
illness across the world. Although primarily affecting the lungs, the SARS-CoV-2 virus also …

Is the endothelium the missing link in the pathophysiology and treatment of COVID-19 complications?

P Castro, M Palomo, AB Moreno-Castaño… - … drugs and therapy, 2022 - Springer
Patients with COVID-19 present a wide spectrum of disease severity, from asymptomatic
cases in the majority to serious disease leading to critical care and even death. Clinically …

COVID-19 and microvascular disease: pathophysiology of SARS-CoV-2 infection with focus on the renin-angiotensin system

DA Kasal, A De Lorenzo, E Tibirica - Heart, Lung and Circulation, 2020 - Elsevier
The recently described severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
infected millions of people, with thousands of fatalities. It has prompted global efforts in …